Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional, Observational Real Life Study on NSAIDs Treated Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of Patient Adherence to PPI Treatment

NCT01519375 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01519375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01519375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional, Observational Real Life Study on NSAIDs Treated Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of Patient Adherence to PPI Treatment
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2012
Enrollment
102 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, osteoarthritis, rheumatoid arthritis